Hou Y, Cai Y, Jia Z, Shi S (2020) Risk factors and prevalence of diabetic retinopathy. Med Baltim 99(42):22695. https://doi.org/10.1097/MD.0000000000022695
Article
Google Scholar
Khan SZ, Ajmal N, Shaikh R (2020) Diabetic retinopathy and vascular endothelial growth factor gene insertion/deletion polymorphism. Can J Diabetes 44(3):287–291
Article
Google Scholar
Antonetti DA, Silva PS, Stitt AW (2021) Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol 17(4):195–206. https://doi.org/10.1038/s41574-020-00451-4
Article
PubMed
Google Scholar
Liu W-J et al (2003) Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan. Diabet Med 20(9):727–733. https://doi.org/10.1046/j.1464-5491.2003.01019.x
Article
PubMed
Google Scholar
Liao W-L et al (2018) Multilocus genetic risk score for diabetic retinopathy in the Han Chinese population of Taiwan. Sci Rep 8(1):1–9. https://doi.org/10.1038/s41598-018-32916-y
Article
CAS
Google Scholar
Cabrera AP, Monickaraj F, Rangasamy S, Hobbs S, McGuire P, Das A (2020) Do genomic factors play a role in diabetic retinopathy? J Clin Med 9(1):216. https://doi.org/10.3390/jcm9010216
Article
CAS
PubMed Central
Google Scholar
Han L et al (2014) The associations between VEGF gene polymorphisms and diabetic retinopathy susceptibility: a meta-analysis of 11 case-control studies. J Diabetes Res. https://doi.org/10.1155/2014/805801
Article
PubMed
PubMed Central
Google Scholar
Ferrara N, Gerber H-P, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9(6):669–676
Article
CAS
Google Scholar
Ferrara N, Adamis AP (2016) Ten years of anti-vascular endothelial growth factor therapy. Nat Rev Drug Discovery 15(6):385–403
Article
CAS
Google Scholar
Welch S, Spithoff K, Rumble RB, Maroun J (2010) Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review. Ann Oncol 21(6):1152–1162
Article
CAS
Google Scholar
Kapahi R et al (2014) Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in Punjabi population from North West India. Tumor Biol 35(11):11171–11181. https://doi.org/10.1007/s13277-014-2404-0
Article
CAS
Google Scholar
Amoah V et al (2016) Vascular endothelial growth factor and hypoxia-inducible factor-1α gene polymorphisms and coronary collateral formation in patients with coronary chronic total occlusions. SAGE Open Med 4:2050312116654403
Article
Google Scholar
Cai J, Boulton M (2002) The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye 16(3):242–260
Article
CAS
Google Scholar
Abdel-Fattah RA, Eltanamly RM, Nabih MH, Kamal MM (2016) Vascular endothelial growth factor gene polymorphism is not associated with diabetic retinopathy in Egyptian patients. Middle East Afr J Ophthalmol 23(1):75–78. https://doi.org/10.4103/0974-9233.171760
Article
PubMed
PubMed Central
Google Scholar
Wat N, Wong RL, Wong IY (2016) Associations between diabetic retinopathy and systemic risk factors. Hong Kong Med J 22(6):589–599
CAS
PubMed
Google Scholar
Amer AK et al (2020) Vascular endothelial growth factor +405G/C polymorphism as a predictor of diabetic retinopathy. Bull Natl Res Centre 44(1):54. https://doi.org/10.1186/s42269-020-00287-y
Article
Google Scholar
Rafferty J, Owens DR, Luzio SD, Watts P, Akbari A, Thomas RL (2020) Risk factors for having diabetic retinopathy at first screening in persons with type 1 diabetes diagnosed under 18 years of age. Eye 38:2840–2847. https://doi.org/10.1038/s41433-020-01326-8
Article
Google Scholar
Yin L, Zhang D, Ren Q, Su X, Sun Z (2020) Prevalence and risk factors of diabetic retinopathy in diabetic patients: a community based cross-sectional study. Medicine 99(9):e19236. https://doi.org/10.1097/MD.0000000000019236
Article
PubMed
PubMed Central
Google Scholar
Semenza GL (2019) Pharmacologic targeting of hypoxia-inducible factors. Annu Rev Pharmacol Toxicol 59:379–403
Article
CAS
Google Scholar
Catrina S-B, Zheng X (2021) Hypoxia and hypoxia-inducible factors in diabetes and its complications. Diabetologia 64:709–716
Article
CAS
Google Scholar
Gu HF et al (2013) Impact of the hypoxia-inducible factor-1 α (HIF1A) Pro582Ser polymorphism on diabetes nephropathy. Diabetes Care 36(2):415–421
Article
CAS
Google Scholar
Persson P, Palm F (2017) Hypoxia-inducible factor activation in diabetic kidney disease. Curr Opin Nephrol Hypertens 26(5):345–350
Article
CAS
Google Scholar
Lee YS et al (2014) Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity. Cell 157(6):1339–1352
Article
CAS
Google Scholar
Botusan IR et al (2008) Stabilization of HIF-1α is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci 105(49):19426–19431
Article
CAS
Google Scholar
Sato Y et al (2011) Cellular hypoxia of pancreatic β-cells due to high levels of oxygen consumption for insulin secretion in vitro. J Biol Chem 286(14):12524–12532
Article
CAS
Google Scholar
Arden GB, Sivaprasad S (2011) Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr Diabetes Rev 7(5):291–304
Article
CAS
Google Scholar
Ning W, Chu TJ, Li CJ, Choi AM, Peters DG (2004) Genome-wide analysis of the endothelial transcriptome under short-term chronic hypoxia. Physiol Genomics 18(1):70–78
Article
CAS
Google Scholar
Baze MM, Schlauch K, Hayes JP (2010) Gene expression of the liver in response to chronic hypoxia. Physiol Genomics 41(3):275–288
Article
CAS
Google Scholar
Polotsky VY et al (2010) Intermittent and sustained hypoxia induce a similar gene expression profile in human aortic endothelial cells. Physiol Genomics 41(3):306–314
Article
CAS
Google Scholar
Al-Mehdi A-B et al (2012) Perinuclear mitochondrial clustering creates an oxidant-rich nuclear domain required for hypoxia-induced transcription. Sci Signal 5(231):ra47
Article
Google Scholar
Albertson AJ, Bohannon AS, Hablitz JJ (2017) HCN channel modulation of synaptic integration in GABAergic interneurons in malformed rat neocortex. Front Cell Neurosci 11:109
Article
Google Scholar
Semenza GL (2000) HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88:1474–1480
Article
CAS
Google Scholar
Semenza GL (2000) HIF-1: using two hands to flip the angiogenic switch. Cancer Metastasis Rev 19(1):59–65
Article
CAS
Google Scholar
Harper SJ, Bates DO (2008) VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer 8(11):880–887
Article
CAS
Google Scholar
Biselli-Chicote PM, Oliveira A, Pavarino EC, Goloni-Bertollo EM (2012) VEGF gene alternative splicing: pro-and anti-angiogenic isoforms in cancer. J Cancer Res Clin Oncol 138(3):363–370
Article
CAS
Google Scholar
Paine SK, Mondal LK, Borah PK, Bhattacharya CK, Mahanta J (2017) Pro-and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy. Mol Vis 23:356
CAS
PubMed
PubMed Central
Google Scholar
Hu W, Wang R, Li J, Zhang J, Wang W (2016) Association of irisin concentrations with the presence of diabetic nephropathy and retinopathy. Ann Clin Biochem 53(1):67–74
Article
CAS
Google Scholar
Gonzalez-Salinas R et al (2017) Evaluation of VEGF gene polymorphisms and proliferative diabetic retinopathy in Mexican population. Int J Ophthalmol 10(1):135–139. https://doi.org/10.18240/ijo.2017.01.22
Article
PubMed
PubMed Central
Google Scholar
Mesquita J, Castro-de-Sousa JP, Vaz-Pereira S, Neves A, Passarinha LA, Tomaz CT (2018) Evaluation of the growth factors VEGF-a and VEGF-B in the vitreous and serum of patients with macular and retinal vascular diseases. Growth Factors 36(1–2):48–57
Article
CAS
Google Scholar
Ahuja S, Saxena S, Akduman L, Meyer CH, Kruzliak P, Khanna VK (2019) Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy. Int J Retina Vitreous 5(1):1–6
Article
CAS
Google Scholar
Abu-Yaghi NE, Abu Tarboush NM, Abojaradeh AM, Al-Akily AS, Abdo EM, Emoush LO (2020) Relationship between serum vascular endothelial growth factor levels and stages of diabetic retinopathy and other biomarkers. J Ophthalmol 2020:1–7
Article
Google Scholar
Zhou Z, Ju H, Sun M, Chen H (2019) Serum vascular endothelial growth factor levels correlate with severity of retinopathy in diabetic patients: a systematic review and meta-analysis. Dis Markers 2019:e9401628. https://doi.org/10.1155/2019/9401628
Article
CAS
Google Scholar
Awata T et al (2005) Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Res Commun 333(3):679–685
Article
CAS
Google Scholar
Hu L, Gong C, Chen X, Zhou H, Yan J, Hong W (2021) Associations between vascular endothelial growth factor gene polymorphisms and different types of diabetic retinopathy susceptibility: a systematic review and meta-analysis. J Diabetes Res 221:1–12
Google Scholar
Churchill AJ et al (2008) VEGF polymorphisms are associated with severity of diabetic retinopathy. Invest Ophthalmol Vis Sci 49(8):3611–3616. https://doi.org/10.1167/iovs.07-1383
Article
PubMed
Google Scholar
Yang X et al (2011) Polymorphisms in the vascular endothelial growth factor gene and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes. Mol Vis 17:3088–3096
CAS
PubMed
PubMed Central
Google Scholar
Yang X et al (2014) Candidate gene association study for diabetic retinopathy in Chinese patients with type 2 diabetes. Mol Vis 20:200
PubMed
PubMed Central
Google Scholar
Fan X et al (2014) Association of polymorphisms in the vascular endothelial growth factor gene and its serum levels with diabetic retinopathy in Chinese patients with type 2 diabetes: a cross-sectional study. Chin Med J 127(4):651–657
CAS
PubMed
Google Scholar
Kapahi R et al (2014) Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in Punjabi population from North West India. Tumour Biol 35(11):11171–11181. https://doi.org/10.1007/s13277-014-2404-0
Article
CAS
PubMed
Google Scholar
Bates DO et al (2002) VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Can Res 62(14):4123–4131
CAS
Google Scholar
Apte RS, Chen DS, Ferrara N (2019) VEGF in signaling and disease: beyond discovery and development. Cell 176(6):1248–1264
Article
CAS
Google Scholar
Marsh S et al (2000) Hypoxic induction of vascular endothelial growth factor is markedly decreased in diabetic individuals who do not develop retinopathy. Diabetes Care 23(9):1375–1380. https://doi.org/10.2337/diacare.23.9.1375
Article
CAS
PubMed
Google Scholar
Suganthalakshmi B et al (2006) Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis 12(1):336–341
CAS
PubMed
Google Scholar